Harris & Harris Group - aVenture Asset Manager Research
Harris & Harris Group
Operating Status: Operating
Harris and Harris Group, Inc.: Transforming disruptive research into innovative businesses.
Location
New York City, NY, US
Founded
1988
Harris & Harris Group, Inc. focuses on transforming disruptive research into innovative businesses. The firm typically invests in Series A and Series B rounds, supporting companies that are at the forefront of technological and scientific advancements. Their investment size varies depending on the stage and potential of the business, with notable investments in sectors such as biotechnology and nanotechnology.
Notable portfolio companies include Mersana Therapeutics, NanoOpto, Petra Pharma, and Senova Systems. Harris & Harris Group is known for its strategic investment philosophy, emphasizing the commercialization of groundbreaking research. The firm provides unique value-add services to its portfolio companies, leveraging deep industry expertise and a robust network to foster growth and innovation.
Harris & Harris Group - Portfolio Snapshot
Portfolio activity breakdown across disclosed investments and stages
Portfolio Companies4
Current Portfolio Count2
Total Portfolio Exits1
Top Investment Stages
Series A2 (66.7%)
Series B1 (33.3%)
Stage Mix
Series A 67%Series B 33%
Concentration shown as share of disclosed investments by stage.
